These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2508064)

  • 41. In a model of immunoglobulin heavy-chain (IGH)/MYC translocation, the Igh 3' regulatory region induces MYC expression at the immature stage of B cell development.
    Yan Y; Park SS; Janz S; Eckhardt LA
    Genes Chromosomes Cancer; 2007 Oct; 46(10):950-9. PubMed ID: 17639584
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
    Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
    Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Early B-cell factor (EBF) down-regulates immunoglobulin heavy chain intron enhancer function in a plasmacytoma cell line.
    Akerblad P; Sigvardsson M; Leanderson T
    Scand J Immunol; 1996 Jul; 44(1):89-92. PubMed ID: 8693297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery platform for inhibitors of IgH gene enhancer activity.
    Dolloff NG
    Cancer Biol Ther; 2019; 20(4):571-581. PubMed ID: 30481117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clonal diversification of primary BALB/c plasmacytomas harboring T(12;15) chromosomal translocations.
    Kovalchuk AL; Mushinski EB; Janz S
    Leukemia; 2000 May; 14(5):909-21. PubMed ID: 10803525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gene localization on sorted chromosomes: definitive evidence on the relative positioning of genes participating in the mouse plasmacytoma-associated typical translocation.
    Wirschubsky Z; Ingvarsson S; Carstenssen A; Wiener F; Klein G; Sümegi J
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6975-9. PubMed ID: 2995997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid amplification of immunoglobulin heavy chain switch (IGHS) translocation breakpoints using long-distance inverse PCR.
    Sonoki T; Willis TG; Oscier DG; Karran EL; Siebert R; Dyer MJ
    Leukemia; 2004 Dec; 18(12):2026-31. PubMed ID: 15496980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Deletional remodeling of c-myc-deregulating chromosomal translocations.
    Kovalchuk AL; Müller JR; Janz S
    Oncogene; 1997 Nov; 15(19):2369-77. PubMed ID: 9393881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Products of a reciprocal chromosome translocation involving the c-myc gene in a murine plasmacytoma.
    Stanton LW; Yang JQ; Eckhardt LA; Harris LJ; Birshtein BK; Marcu KB
    Proc Natl Acad Sci U S A; 1984 Feb; 81(3):829-33. PubMed ID: 6322170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Murine and human 3'IgH regulatory sequences.
    Birshtein BK; Chen C; Saleque S; Michaelson JS; Singh M; Little RD
    Curr Top Microbiol Immunol; 1997; 224():73-80. PubMed ID: 9308230
    [No Abstract]   [Full Text] [Related]  

  • 51. Is extramedullary plasmacytoma an oligoclonal tumour with clonal selection during tumour progression?
    Tzen CY; Mau BL; Huang YW; Huang MJ; Chen CP
    Histopathology; 2006 Mar; 48(4):469-71. PubMed ID: 16487374
    [No Abstract]   [Full Text] [Related]  

  • 52. Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affect promoter usage: implications for the site of normal c-myc regulation.
    Yang JQ; Bauer SR; Mushinski JF; Marcu KB
    EMBO J; 1985 Jun; 4(6):1441-7. PubMed ID: 2992931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avoidance of base runs in switch regions of immune-system genes.
    Perrin P; Grantham R
    Mol Biol Evol; 1988 Mar; 5(2):141-53. PubMed ID: 3130537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of two distinct MYC breakpoint clusters and their association with various IGH breakpoint regions in the t(8;14) translocations in sporadic Burkitt-lymphoma.
    Busch K; Keller T; Fuchs U; Yeh RF; Harbott J; Klose I; Wiemels J; Novosel A; Reiter A; Borkhardt A
    Leukemia; 2007 Aug; 21(8):1739-51. PubMed ID: 17541401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of Ig gene expression by Ig binding factors. Suppression of alpha-H chain and lambda-2-L chain mRNA accumulation in MOPC-315 by IgA-binding factor.
    Roman S; Moore JS; Darby C; Müller S; Hoover RG
    J Immunol; 1988 May; 140(10):3622-30. PubMed ID: 3129498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
    Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
    Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas.
    Adams JM; Gerondakis S; Webb E; Corcoran LM; Cory S
    Proc Natl Acad Sci U S A; 1983 Apr; 80(7):1982-6. PubMed ID: 6572957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DNA sequence analysis of the genetic recombination between Igh6 and Myc in an uncommon BALB/c plasmacytoma, TEPC 1194.
    Kovalchuk AL; Potter M; Janz S
    Immunogenetics; 1996; 44(2):151-6. PubMed ID: 8662079
    [No Abstract]   [Full Text] [Related]  

  • 59. Myc translocations in B cell and plasma cell neoplasms.
    Janz S
    DNA Repair (Amst); 2006 Sep; 5(9-10):1213-24. PubMed ID: 16815105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunoglobulin genes and the c-myc oncogene in plasmacytomagenesis.
    Potter M
    Mt Sinai J Med; 1986 Mar; 53(3):216-22. PubMed ID: 3084962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.